title: The osteogenic potential of two composite graft systems using osteogenin.
abstract: The purpose of this study was to determine the quantity of new bone formation in critical sized calvaria defects in rats treated with two composite graft systems. The systems consisted of either a combination of the bone inductive protein (osteogenin) plus type I collagen (Os + C) or the combination of osteogenin with coralline hydroxyapatite (Os + HA). Additional treatments consisted of coralline hydroxyapatite (HA) or untreated control defects. After 28 days the calvaria were recovered and processed for quantitative radiography (radiomorphometry) and histomorphometry. Histomorphometric results were based on quantitation of regenerated trabecular bone. Results indicated that the Os + C combination produced substantially more bone than the Os + HA, HA, or control groups (P less than 0.05). Radiomorphometric assessment was based on the detection of radiopacity in the calvarial wounds. Due to the radiopaque property of HA, it was not possible to accurately quantitate the radiopacity of the regenerating bone from HA and host bone. Therefore, conclusions about the efficacy of the treatments must be derived from histomorphometric data. Results from histometric measurements of healing indicate that the Os + C combination has the greatest potential for regenerating calvarial bone defects. The potential for osteogenin in regenerating alveolar bone lost due to periodontal disease is suggested by these studies.
authors.affiliation: Periodontics Department, United States Naval Academy, Annapolis, MD.
authors.forename: B A
authors.initials: BA
authors.lastname: Doll
authors.forename: H J
authors.initials: HJ
authors.lastname: Towle
authors.forename: J O
authors.initials: JO
authors.lastname: Hollinger
authors.forename: A H
authors.initials: AH
authors.lastname: Reddi
authors.forename: J T
authors.initials: JT
authors.lastname: Mellonig
mesh_terms: D000818:Animals; D055398:Bone Morphogenetic Protein 3; D019485:Bone Morphogenetic Proteins; D001861:Bone Regeneration / Q000187:drug effects*; D001842:Bone and Bones / Q000033:anatomy & histology / Q000187:drug effects; D002417:Cattle; D003063:Cnidaria; D003094:Collagen / Q000494:pharmacology*; D003238:Connective Tissue / Q000033:anatomy & histology; D017886:Durapatite; D006133:Growth Substances / Q000494:pharmacology*; D006882:Hydroxyapatites / Q000494:pharmacology*; D010012:Osteogenesis / Q000187:drug effects*; D011506:Proteins / Q000494:pharmacology*; D051381:Rats; D012886:Skull
chemical_list: C525759:Bmp3 protein, rat; D055398:Bone Morphogenetic Protein 3; D019485:Bone Morphogenetic Proteins; D006133:Growth Substances; D006882:Hydroxyapatites; D011506:Proteins; D003094:Collagen; D017886:Durapatite